A non-haemagglutinating form of Clostridium difficile toxin A

References

1. Bartlett J. G., Chang T. W., Gurwith M., Gorbach S. L., Onderdonk A. B. Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. N Engl J Med 1978; 298:531–534
   [Google Scholar]
2. Borriello S. P., Larson H. E. Antibiotic and pseudomembranous colitis. J Antimicrob Chemother 1981; 7: Suppl A 53–62
   [Google Scholar]
3. George W. L., Sutter V. L., Goldstein E. J. C., Ludwig S. L., Finegold S. M. Aetiology of antimicrobial-agent-associated colitis. Lancet 1978; 1:802–803
   [Google Scholar]
4. Larson H. E., Price A. B., Honour P., Bordello S. P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978; 1:1063–1066
   [Google Scholar]
5. Banno Y., Kobayashi T., Kono H., Watanabe K., Ueno K., Nozawa Y. Biochemical characterization and biologic actions of two toxins (D–1 and D–2) from Clostridium difficile. Rev Infect Dis 1984; 6: Suppl 1S11–S20
   [Google Scholar]
6. Lyerly D. M., Lockwood D. E., Richardson S. H., Wilkins T. D. Biological activities of toxins A and B of Clostridium difficile. Infect Immun 1982; 35:1147–1150
   [Google Scholar]
7. Mitchell T. J., Ketley J. M., Haslam S. C. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 1986; 27:78–85
   [Google Scholar]
8. Borriello S. P., Barclay F. E., Welch A. R. Host and microbial determinants of the spectrum of Clostridium difficile mediated gastrointestinal disorders. In Erlandsen S. L., Jordan M. C., Wells C. L., Rusch V. (eds) Microecology and therapy vol 15 Herborn-Dill, FRG: Institut für Mikroökologie; 1985231
   [Google Scholar]
9. Lyerly D. M., Saum K. E., MacDonald D. K., Wilkins T. D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun 1985; 47:349–352
   [Google Scholar]
10. Kriven H. C., Clarke G. F., Smith D. F., Wilkins T. D. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Galα13 Galβ14GlcNAc. Infect Immun 1986; 53:573–581
    [Google Scholar]
11. Tucker K. D., Wilkins T. D. Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X and Y. Infect Immun 1991; 59:73–78
    [Google Scholar]
12. Krivan H. C., Wilkins T. D. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun 1987; 55:1873–1877
    [Google Scholar]
13. Kamiya S., Reed P. J., Borriello S. P. Analysis of purity of Clostridium difficile toxin A derived by affinity chromatography on immobilized bovine thyroglobulin. FEMS Microbiol Lett 1988; 56:331–336
    [Google Scholar]
14. Kamiya S., Reed P. J., Bordello S. P. Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction. J Med Microbiol 1989; 30:69–77
    [Google Scholar]
15. Thelestam M., Florin I. Cytopathogenic action of Clostridium difficile toxins. J Toxicol-Toxin Rev 1984; 3:139–180
    [Google Scholar]
16. Borriello S. P., Barclay F. E., Reed P. J., Welch A. R., Brown J. D., Burdon D. W. Analysis of latex agglutination test for Clostridium difficile toxin A (D–1) and differentiation between C difficile toxins A and B and latex reactive protein. J Clin Pathol 1987; 40:573–580
    [Google Scholar]
17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680–685
    [Google Scholar]
18. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248–254
    [Google Scholar]
19. Burnette W. N. “Western blotting”. Electrophoretic transfer of proteins from sodium dodecyl sulphate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112:195–203
    [Google Scholar]
20. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350–4354
    [Google Scholar]
21. Seddon S. V., Borriello S. P. A chemically defined and minimal medium for Clostridium difficile. Lett Appl Microbiol 1989; 9:237–239
    [Google Scholar]
22. Giuliano M., Piemonte F., Gianfrilli P. M. Production of an enterotoxin different from toxin A by Clostridium difficile. FEMS Microbiol Lett 1988; 50:191–194
    [Google Scholar]
23. Borriello S. P., Davies H. A., Kamiya S., Reed P. J., Seddon S. Virulence factors of Clostridium difficile. Rev Infect Dis 1990; 12: Suppl 2S185–S191
    [Google Scholar]
24. Lyerly D. M., Krivan H. C., Wilkins T. D. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1:1–18
    [Google Scholar]
25. Taylor N. S., Thome G. M., Bartlett J. G. Comparison of two toxins produced by Clostridium difficile. Infect Immun 1981; 34:1036–1043
    [Google Scholar]
26. Libby J. M., Jortner B. S., Wilkins T. D. Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun 1982; 36:822–829
    [Google Scholar]
27. Rautenberg P., Stender F. Characterization of immunogenic p230 as the toxin A of Clostridium difficile. FEMS Microbiol Lett 1986; 37:1–7
    [Google Scholar]
28. Seddon S. V., Davies H. A., Borriello S. P. The effect of nutrition on the expression of known and putative virulence factors of Clostridium difficile. Microb Ecol Hlth Dis 1990; 4:303–309
    [Google Scholar]
29. Lyerly D. M., Phelps C. J., Toth J., Wilkins T. D. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun 1986; 54:70–76
    [Google Scholar]
30. Tucker K. D., Carrig P. E., Wilkins T. D. Toxin A of Clostridium difficile is a potent cytotoxin. J Clin Microbiol 1990; 28:869–871
    [Google Scholar]